---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-055990"
form_type: "8-K"
ticker: "KNSA"
cik: "0001730430"
company_name: "Kiniksa Pharmaceuticals International, plc"
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:48:16.397842+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Kiniksa shareholders elect all director nominees and approve all 13 proposals at annual meeting

## Summary
- All 10 director nominees elected; Stephen R. Biggar received 15.3M against votes, Felix J. Baker 12.3M against.
- Say-on-pay (Prop 10) passed with 49.1M for, 550.7K against.
- Authority to allot shares up to ~35% of share capital (Prop 11) passed: 41.2M for, 11.2M against.
- Disapplication of pre-emption rights (Prop 12) passed: 40.7M for, 11.7M against.
- Preference share redemption to create distributable reserves (Prop 13) passed with 52.4M for, 23.2K against.

## SEC filing metadata
- accession: 0001104659-25-055990
- form_type: 8-K
- ticker: KNSA
- cik: 0001730430
- company_name: Kiniksa Pharmaceuticals International, plc
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1730430/000110465925055990/0001104659-25-055990-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1730430/000110465925055990/tm2517053d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-055990
- JSON: https://secwatch.observer/filing/0001104659-25-055990.json
- Plain text: https://secwatch.observer/filing/0001104659-25-055990.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.